|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/51 | |
| A61K 47/12 | |||
| A61K 31/506 | |||
| A61P 31/00 |
| (11) | Patento numeris | 2895156 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13771005.9 |
| Europos patento paraiškos padavimo data | 2013-09-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-07-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/059936 |
| Data | 2013-09-16 |
| (87) | Numeris | WO 2014/043618 |
| Data | 2014-03-20 |
| (30) | Numeris | Data | Šalis |
| 201261702037 P | 2012-09-17 | US |
| (72) |
FIGUEIREDO, Maria, US
PEEKE, Erick, US
DEWITT, David, US
VAN GEEN HOVEN, Christina, US
TROIANO, Greg, US
WRIGHT, James, US
SONG, Young-Ho, US
WANG, Hong, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017-5755,
US
|
| (54) | PROCESS FOR PREPARING THERAPEUTIC NANOPARTICLES |
| PROCESS FOR PREPARING THERAPEUTIC NANOPARTICLES |